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ROSRespiratory Complex II of the mitochondrial inner membrane serves as a link between the tricarboxylic acid
cycle and the electron transport chain. Complex II dysfunction has been implicated in a wide range of herita-
ble mitochondrial diseases, including cancer, by a mechanism that likely involves the production of reactive
oxygen species (ROS). Using Complex II enzymes reconstituted into nanoscale lipid bilayers (nanodiscs) with
varying lipid composition, we demonstrate for the ﬁrst time that the phospholipid environment, speciﬁcally
the presence of cardiolipin, is critical for the assembly and enzymatic activity of the complex, as well as in the
curtailment of ROS production.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Respiratory Complexes I to V of the mitochondrial inner mem-
brane (IM) generate the majority of ATP in eukaryotic cells by oxida-
tive phosphorylation (OXPHOS). Among eukaryotic biomembranes,
the mitochondrial IM is one of the most protein-rich (up to ~70%
protein by weight), with a lipid composition dominated by the
aminoglycerophospholipids phosphatidylcholine (PC) and phospha-
tidylethanolamine (PE) (each ~30–40% total phospholipid) as well
as the mitochondria-speciﬁc dimeric phospholipid cardiolipin (CL,
~15–20% total phospholipid) [1,2]. Most OXPHOS enzymes bind CL
with high afﬁnity and require CL for optimal activity [3,4]; moreover,
CL has been implicated in the assembly and stability of respiratory
chain supercomplexes that facilitate substrate channeling [5].
Mitochondrial respiratory Complex II is a tetrameric enzyme com-
posed of a soluble catalytic heterodimer in thematrix and a heterodimer
of membrane subunits in the IM (Supplementary Fig. S1) [6–8]. The cat-
alytic dimer consists of the ﬂavoprotein SdhA [Sdh1p] with a covalently
bound FAD cofactor and SdhB [Sdh2p] that contains three dissimilarPIP, dichlorophenolindophenol;
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bound subunits, SdhC [Sdh3p] and SdhD [Sdh4p], coordinate a b-type
heme and contain a quinone-binding site [9,10]. Complex II has two en-
zymatic activities that can be monitored by established assays. As an
enzyme of the tricarboxylic acid (TCA) cycle, Complex II exhibits suc-
cinate dehydrogenase (SDH) activity, whereby the soluble SdhA/B
catalytic dimer in the matrix oxidizes succinate to fumarate. As a
component of the electron transport chain, Complex II also mediates
succinate:ubiquinone oxidoreductase (SQR) activity, whereby elec-
trons from succinate oxidation are transferred to the quinone bind-
ing pocket at the interface of the SdhC/D membrane heterodimer,
reducing ubiquinone (Q) to ubiquinol (QH2). In contrast to respirato-
ry Complexes I, III, IV and V, Complex II does not appear to assemble
into CL-stabilized supercomplexes, nor is there currently evidence
that its activity is CL-dependent.
Genetic defects in Complex II are associated with a wide spectrum
of human diseases [11]. For example, mutations in the SDHB, SDHC,
and SDHD genes have been linked to heritable forms of para-
ganglioma, pheochromocytoma, and colon and gastric cancers
[12,13]. While the molecular mechanism of tumor formation by
these mutations remains controversial, emerging evidence implicates
the generation of reactive oxygen species (ROS) by Complex II. Most
endogenous ROS, particularly superoxide (O2−), are generated by ex-
cessive electron leakage from mitochondrial respiratory complexes.
Complexes I and III are considered the strongest ROS generators
[14]; however, in support of structural considerations [7], some stud-
ies have reported O2− production by Complex II as well [15,16]. Mech-
anistically, this can occur by an uncoupling of SDH and SQR activity
(i.e. electron transfer to Q is blocked while succinate oxidation pro-
ceeds unabated). This block in electron ﬂux and resulting O2− produc-
tion by Complex II can result from point mutations in SdhB, SdhC, and
SdhD [17,18], inhibitors of Q binding such as TTFA [19] and physical
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sult of this disruption, electrons can react with O2 to form O2− either
by autoxidation of reduced ﬂavin or Fe–S groups, or directly from sta-
bilized ubisemiquinone intermediates.
Many studies have focused on the effects of individual SDH muta-
tions; however, the potential role that lipids may play in Complex II ac-
tivity is unknown. To address this issue,we have reconstituted Complex
II into nanoscale model membrane particles termed nanodiscs (NDs)
with deﬁned lipid compositions. NDs are discoidal lipid bilayers
encircled by amphipathic membrane scaffolding proteins (MSPs) that
render them soluble and amenable to solution-based studies [20]. As
modelmembrane platforms, NDs have beenwidely used to reconstitute
a wide range of fully active membrane proteins and complexes. To
study the effects of the lipid environment on Complex II activity, this
system offers several advantages. In contrast to detergent-solubilized
samples, the complex is studied in lamellar (not micellar) context. In
contrast to liposomes, NDs are monodisperse and allow unrestricted
experimental access to both sides of the complex. In contrast to in
organello studies, the lipid content can be precisely deﬁned and activity
measured in isolation [20]. Notably, a recent study has shown that re-
spiratory oxidases could be functionally reconstituted into NDs [21].
In the present report, we demonstrate that a native-like IM lipid compo-
sition (speciﬁcally, the presence of CL) is required for optimal stability
and activity of Complex II, as well as curtailment of ROS production.
2. Materials and methods
2.1. Materials
Lipids were purchased from Avanti Polar Lipids (Alabaster, AL).
Chemicals were obtained from Sigma Aldrich (St. Louis, MO) or Ther-
mo Fisher Scientiﬁc, Inc. (Pittsburg, PA).
2.2. Mitochondria solubilization
Mitochondria isolated from Saccharomyces cerevisiae (strain D273-
10B) as previously described [22] were solubilized in buffer (50 mM
potassium phosphate [pH 7.4], 50 mM KCl) with DDM at a ﬁnal deter-
gent:mitochondrial protein ratio of 1.5 g:1.0 g (~3% [w/v] DDM). Mito-
chondria were incubated at RT for 25 min and then subjected to a
clarifying centrifugation step to remove non-solubilized membranes.
Supernatant containing solubilized mitochondrial IM proteins was re-
moved for use in ND assembly.
2.3. Lipid preparation
Lipid stocks (DMPC or POPC), POPC/POPE lipid mix (50:50 mol%),
POPC/POPE/POPG lipid mix (40:40:20 mol%) or biomimetic lipid mix
(POPC, POPE, and CL in 40:40:20 mol%) in chloroform were dried
under a N2 stream and desiccated under vacuum overnight to remove
all traces of organic solvent, as described [23]. Lipid was reconstituted
in MSP buffer (20 mM Tris–HCl [pH 7.4], 100 mM NaCl, 0.5 mM
EDTA) with 59 mM sodium cholate and bath sonicated.
2.4. ND assembly
Membrane Scaffolding Protein (MSP1E3D1) was synthesized and
puriﬁed as described [24]. Lipid, MSP1E3D1 (in lipid: MSP1E3D1
ratios of 122:1 [DMPC], 108:1 [POPC], 140:1 [POPC/POPE], 143:1
[POPC/POPE/POPG], and 143:1 [biomimetic]), DDM-solubilized mito-
chondria, andMSP buffer ([cholate]=14.8 mM)were incubated at RT
for 30 min. Pre-hydrated Bio-Beads SM Hydrophobic Interaction Ad-
sorbent (Bio-Rad Laboratories, Inc., Hercules, CA) were added and ro-
tated for 2 h to remove detergent and allow ND self-assembly to
proceed. Following bead removal and incubation with Ni-NTA aga-
rose, samples were subjected to step gradients of MSP buffer andimidazole (up to 400 mM) to isolate NDs with His-tagged MSP. The
ﬁrst two elution samples were combined (E*), dialyzed into MSP buff-
er to remove imidazole and concentrated in Centricon 3000 MWCO
tubes in an Eppendorf Centrifuge 5804R.2.5. Size exclusion chromatography
A GE Healthcare ÄKTA Puriﬁer systemwith a Superdex 200 10/300
GL column was used for gel ﬁltration chromatography, monitoring
absorbance at 280 nm. The following standards with previously
reported Stokes diameters [25] were used to calibrate the column:
blue dextran (8.3 mL), β-amylase (12.2 mL, 7.4 nm), alcohol dehy-
drogenase (13.5 mL), BSA (14.3 mL, 6.58 nm), carbonic anhydrase
(16.7 mL, 4.0 nm) and cytochrome c (18.1 mL, 3.76 nm).2.6. Electron microscopy
ND samples containing a biomimetic blend of lipids only (empty)
and those containing mitochondrial membrane proteins (loaded)
were imaged by negative staining (uranyl acetate) transmission elec-
tron microscopy after 100× dilution in ddH2O. Images were collected
at 180,000× magniﬁcation on a Tecnai Biotwin G2 Spirit transmission
electron microscope.2.7. SDS-PAGE and immunoblot analysis
To detect the presence of FAD, gels were scanned on a Bio-Rad
Pharos FX Plus Molecular Imager with external lasers using Quantity
One software (version 4.6.9) under the FITC ﬂuorescent setting
(488 nm laser, 530 nm emission ﬁlter). For these gels, the high MW
band represents Sdh1p-FAD and the lower-migrating bands repre-
sent unrelated mitochondrial ﬂavoproteins [26]. The same gel was
subsequently stained with Coomassie blue. Immunoblots were con-
ducted with primary antibodies against Sdh1p (αSdh1p, a generous
gift of Dr. Bernard Lemire) and Sdh3p (αSdh3p, custom made, Paciﬁc
Immunology) with Amersham ECL Plex Cy5-conjugated secondary
antibody. Blots were scanned on the Bio-Rad Imager under the Cy5
ﬂuorescent setting (635 nm laser, 695 nm emission ﬁlter).2.8. Complex II activity assays
Assays were conducted as previously described [27] on an Amer-
sham Biosciences Ultraspec 2100 pro UV/Vis Spectrophotometer in
1 cm quartz cuvettes following the extinction of DCPIP absorbance
(ε600=20.7 mM−1 cm−1). Intact mitochondria were isolated as de-
scribed [22] from S. cerevisiae wild type strain (D273-10B) or from
S. cerevisiae deletion mutant YKO strain Δcrd1 (Open Biosystems),
which lacks the cardiolipin synthase gene CRD1.2.8.1. SDH activity (PMS-mediated)
Master mix (50 mM Tris [pH 7.5], 5 mM Succinate [pH 7.5],
0.5 mM DCPIP, 0.1 mM PMS) was added to the sample and incubated
for 10 min prior to measurements.2.8.2. SQR activity (DB-mediated)
Samples were pre-incubated with 10 μM DB before adding master
mix (50 mM KPO4 [pH 7.5], 1 mM EDTA, 62 μM DCPIP) and 0 to
20 mMK-Succinate [pH 7.5] prior to measurements. Where indicated,
samples were pre-incubated with 2.5 mM TTFA for 5 min prior to DB
incubation. DCPIP reduction was monitored over the linear range
(30 s for all nanodisc and Table 1 values; 20 s for temperature-
sensitivity experiments with intact mitochondria).
Table 1
Speciﬁc SQR activity of Complex II.













a Errors shown represent standard errors.
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Analyses were performed with commercially available kits (Bio-
Vision, Inc.) following manufacturer's instructions. Brieﬂy, isolated mi-
tochondria and ND samples from each lipid type were resuspended in
Assay Buffer containing NP-40 detergent (BioVision FAD Assay Kit)
and centrifuged to remove insoluble material. Samples were then
deproteinized byperchloric acid precipitation (BioVisionDeproteinizing
Sample Prep Kit) and the resulting sample was used to determine the
quantity of FAD. A colorimetric assay was used to determine amount
of FAD by adding FAD standards or the sample to a mixture of Assay
Buffer, the OxiRed Probe, and Enzyme Mix from the FAD Assay Kit. Ab-
sorbance was read at 570 nm and the reaction was linear with time to
an absorbance of 1.8. These valueswere used to determine the FAD con-
tent of samples utilized for SQR activity assay analysis (represented as
μmol DCPIP reduced min−1 μmol FAD−1). Speciﬁc SQR activities for in-
tact mitochondria (Table 1) were consistent with published values
(e.g. [28]).
2.10. ROS production assay
Analyses were performed using the MitoSOX assay kit (Invitrogen
Molecular Probes) following manufacturer's instructions. Brieﬂy, ND
samples from each lipid type were pre-incubated with 10 μM DB,
mixed with 16 mM K-Succinate and 10 μM MitoSOX reagent and in-
cubated for 10 min at RT and added to 10 μg salmon testes DNA.
Where indicated, samples were pre-incubated with 2.5 mM TTFA for
5 min. Fluorescence emission spectra were measured for each sample
pre- and post-DNA addition (λex=510 nm, λem=530–630 nm, 1 s
integration time, 4 nm slit widths).
2.11. Data representation and statistical analysis
SDS-PAGE gels, immunoblot gels, SEC elution proﬁles, and kinetic
analyses are representative of at least three independent experi-
ments. SQR activity is represented as % change (compared to Biomi-
metic ND elution (E*) fractions) in DCPIP absorbance over the initial
30 s time period divided by the initial absorbance. SDH activity is rep-
resented as total% change in DCPIP absorbance compared to Biomi-
metic ND elution (E*) fractions, as with SQR activity. Fluorescence
values for ROS production are represented as background correctedFig. 1. Reconstitution of active Complex II into NDs. (A) Schematic of assembly process to p
ubilization of mitochondria, membrane complexes are added to a reaction containing scaffo
lowing the selective removal of detergent with hydrophobic adsorbents, and elution of the
possess an N-terminal His tag on MSP1E3D1). (B) Size exclusion fractionation of NDs contai
complexes (loaded, red trace). Chromatograms display absorbance at 280 nm (total protein
crographs of empty NDs (left panel) and NDs assembled with mitochondrial membrane pro
Ni-NTA column puriﬁcation of NDs resolved by SDS-PAGE and analyzed as indicated by: (i) C
Sdh1p), and immunoblots with antibodies against (iii) Sdh1p (αSdh1p) and (iv) Sdh3p (αSd
FT: column ﬂow through; W1A–W3B: column wash steps; E1–E3: column elution steps. N
Eadie–Hofstee diagrams (inset) of SQR activity for (i) DDM-solubilized mitochondria (Km=
II (Km=0.37 mM and Vmax=1432.3 μmol DCIP min−1 μmol FAD−1).(empty ND samples) intensities that are normalized according to
the highest emission intensity for that data set and summed to deter-
mine the total area under each curve, which were then relativized
according to the lipid-type of maximum value, POPC. The results pres-
ented for the cytochrome spectra, kinetic analysis, activity assays, and
ROS production assay are shown as means±standard errors of the
means (s.e.m.) of at least three independent experiments. A two-
tailed student T-test (equal variance) was used to determine statisti-
cal signiﬁcance (p≤0.1 or p≤0.01) for activity assay and ROS produc-
tion assay measurements.3. Results and discussion
3.1. Reconstitution of Complex II from isolated mitochondria into NDs
Traditional means of ND reconstitution originate with a single
overexpressed membrane protein or biomembrane whose protein
content consists mostly of a single protein or complex. In this report,
we have optimized the procedure for reconstituting the entire com-
plement of membrane proteins solubilized from mitochondria into
NDs, showing that: (i) a single complex (Complex II in this case)
could be reconstituted in an active state with sufﬁcient yield to accu-
rately measure enzymatic activity among the population of rec-
onstituted proteins, and (ii) the effect of lipids on the assembly and
activity of Complex II could be assayed by synthesizing NDs with dif-
ferent lipid combinations.
By this process, detergent-solubilized membrane proteins from
mitochondria isolated from yeast (S. cerevisiae) were reconstituted
into NDs of a deﬁned lipid composition and the preparations were
isolated by afﬁnity chromatography and exchanged into a buffer com-
patible with our analyses (Fig. 1A). To recapitulate the native IM, we
assembled NDs with a biomimetic blend of lipids that included POPC
(16:0/18:1), POPE (16:0/18:1) and 18:1 CL in molar ratios of
40:40:20, respectively. Based on size exclusion chromatography,
empty NDs prepared without mitochondrial proteins (Fig. 1B, black
trace) had a Stokes diameter consistent with the published value of
~12 nm for this MSP [29]. By comparison, NDs assembled with mito-
chondrial membrane proteins were larger and had a broader hydro-
dynamic size distribution (Fig. 1B, red trace). The reconstitution of
membrane proteins into afﬁnity column-puriﬁed NDs was further
conﬁrmed by gel analysis of total protein content (Supplementary
Fig. S2A) and characteristic cytochrome absorbance spectra (Supple-
mentary Fig. S2B). Transmission electron micrographs showed that
both empty NDs and those containing membrane proteins yielded
particles with homogeneous MSP-limited diameters (Fig. 1C), con-
ﬁrming proper ND assembly.
To assay for the successful reconstitution of intact Complex II
within NDs speciﬁcally, we conducted gel analysis of all afﬁnity chro-
matography fractions and found that Complex II subunits co-eluted
with the scaffolding protein at high imidazole concentrations
(Fig. 1D). To conﬁrm that Complex II retention on the column was in-
deed ND-dependent, we performed mock assembly reactions in the
absence of MSP and found that Complex II subunits eluted in the
ﬂow through (Supplementary Fig. S3). To conﬁrm that Complex IIroduce NDs containing mitochondrial membrane complexes. Following detergent sol-
lding protein (MSP1E3D1) and cholate-solubilized lipids. ND self-assembly occurs fol-
reaction over a nickel afﬁnity column allows for puriﬁcation of assembled NDs (which
ning lipid only (empty, black trace) and NDs assembled with mitochondrial membrane
content), and were calibrated by molecular mass standards (above). (C) Electron mi-
teins (right panel) at 180,000× magniﬁcation. (scale bar=100 nm). (D) Fractions from
oomassie stain, (ii) in-gel ﬂuorometry (to visualize the FAD moiety covalently bound to
h3p). Abbreviations are S: supernatant and P: pellet frommitochondrial solubilization;
ote relative imidazole concentrations depicted above. (E) Michaelis–Menten plots and
0.10 mM and Vmax=51.9 μmol DCIP min−1 μmol FAD−1) and (ii) ND-bound Complex
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Fig. 2. The stability of Complex II is dependent on lipid composition. Membrane proteins from DDM-solubilized mitochondria were reconstituted into NDs with the indicated lipid
compositions and subjected to afﬁnity chromatography to isolate the NDs. Subunits co-eluting with MSP1E3D1 (fractions E1 and E2) were considered to be stably associated with
the NDs; those eluting at the earlier fractions were not stably associated. The ﬂuorescent FAD signal was used as the marker for the soluble dimer and immunodetection with an-
tiserum against Sdh3p (αSdh3p) was used as the marker for the membrane dimer. Column fraction designations are identical to those in Fig. 1D, except supernatant and pellet lanes
are not present.
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the succinate-dependent, decylubiquinone (DB)-mediated reduction of
dichlorophenolindophenol (DCPIP) for both detergent-solubilized mi-
tochondrial membranes and ND preparations (Fig. 1E). While both
preparations showed saturation kinetics with comparable Km values,
we found that Complex II in NDs had a maximal reaction velocity that
was ~30 times that of complexes in detergent. We conclude that
we have reconstituted fully-assembled and catalytically competent
Complex II holoenzymes directly from mitochondrial membranes
into NDs.
3.2. CL promotes Complex II stability
Having optimized the procedures for reconstituting mitochon-
drial complexes into NDs, we had an excellent experimental plat-
form for testing the inﬂuence of lipid composition on the stability
and activity of Complex II. Hence, we performed ND assembly reac-
tions with the following phospholipid compositions (Supplementary
Fig. S4): (i) DMPC (14:0/14:0) only, (ii) POPC (16:0/18:1) only,
(iii) POPC (16:0/18:1) and POPE (16:0/18:1) in a 50:50 molar ratio
and (iv) POPC, POPE and CL in a 40:40:20molar ratio (“biomimetic,” de-
scribed above).
To assay the effects of these lipid compositions on Complex II sta-
bility, we adapted our afﬁnity column puriﬁcation strategy to test for
the association of the Sdh1p/Sdh2p soluble catalytic dimer with the
Sdh3p/Sdh4p membrane-bound subunits (Fig. 2). With each of the
four different lipid compositions, most of the Complex II membrane
subunits (based on αSdh3p immunoblots) were stably incorporated
into NDs (i.e. appearing in the elution fractions, Fig. 2, lanes 8–9),
and very little appeared free in earlier fractions. In contrast, whereasthe soluble dimer (based on FAD ﬂuorescence) was stably associated
with NDs containing a biomimetic lipid composition (Fig. 2, lanes
8–9), a large percentage of the ﬂavoprotein remained unbound (i.e.
appeared in wash steps, Fig. 2, lanes 3–7) for all other preparations.
We therefore conclude that the biomimetic lipid composition stabi-
lized the interaction between the membrane and soluble subunits.
The destabilizing effect was observed when NDs were prepared
with short chain lipids (DMPC only), with longer chain, monounsatu-
rated lipids (POPC only) and with lipid combinations that included
non-bilayer (HII phase) preferring lipids in amounts consistent with
the mitochondrial IM (POPC and POPE). Among our four lipid combi-
nations, the ternary biomimetic composition uniquely contained CL;
we thus conclude that the presence of CL in the bilayer stabilized
the interaction between membrane bound subunits and the catalytic
dimer.3.3. CL is essential for optimal Complex II enzymatic activity
We then measured the catalytic activity of Complex II rec-
onstituted into NDs with the same four lipid compositions as above
(Fig. 3). As described, SQR activity, assayed by electron transfer
from succinate to DCPIP via the Q analog DB, requires an intact
holocomplex; SDH activity, assayed by electron transfer from succi-
nate to DCPIP via the redox mediator PMS, requires only a stable cat-
alytic dimer (Supplementary Fig. S1). SQR activity time course
measurements revealed that complexes reconstituted with biomi-
metic lipids had robust electron transport rates from succinate to
the membrane-bound electron carrier, whereas the transport rates
of complexes reconstituted with all other lipid compositions were
Fig. 3. Enzymatic activity of Complex II reconstituted into NDs of different lipid compo-
sition. Assays were designed to monitor SQR activity (mediated by DB) or SDH activity
(mediated by PMS), in both cases quantiﬁed colorimetrically as the extinction of DCPIP
absorbance. (A) Signal-averaged time course traces of SQR activity for Complex II rec-
onstituted in NDs containing DMPC only (red), POPC only (yellow), POPC with POPE
(green), biomimetic lipids (blue), biomimetic lipids treated with TTFA (blue dotted),
and prepared with biomimetic lipids but without MSP1E3D1 (blue dashed). (B) Rela-
tive SQR activity of column fractions for ND samples with the indicated lipid composi-
tion, determined from the initial reaction velocity (30 s following succinate addition).
(C) Relative SDH activity of column fractions for ND samples with the indicated lipid
compositions. For both panels B and C, E* represents fractions E1 and E2, which were
pooled, and statistical differences are represented in relation to biomimetic NDs
(*=p≤0.1; **=p≤0.01).
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traces). As expected, the negative control sample (mock assembly in
the absence of MSP) showed no SQR activity (Fig. 3A, blue dashed
line). Notably, the potent inhibitor TTFA, which blocks electron ﬂow
by binding at the Q site, reduced our measured rates of catalysis by~83% (Fig. 3A, blue dotted line), conﬁrming that we were monitoring
genuine Complex II SQR activity.
In addition,we performed a comprehensive analysis of SDHand SQR
activities of all fractions from the afﬁnity chromatography steps. The
relative SQR activities were clearly highest in the elution fractions of
NDs with the biomimetic lipid composition (Fig. 3B), consistent with
our observed requirement of CL to form a stable holocomplex (Fig. 2).
The relative SDH activities were highest in the elution fraction for bio-
mimetic samples, but relatively higher in earlier fractions for other
lipid combinations (Fig. 3C), consistent with the observed dissociation
of the catalytic dimer from membrane subunits when CL is lacking
(Fig. 2).
Taken together, the results from Fig. 2 and Fig. 3 demonstrate that
CL is required to stabilize the interaction between the membrane-
bound heterodimer and catalytic heterodimer of Complex II. It has
been previously shown that the soluble SdhA/B dimer, fully active in
SDH activity, dissociates from the membrane in the presence of
chaotropes and organic solvents and more recently that it dissociates
during matrix acidiﬁcation, as would occur during apoptosis [15 and
references therein]. Our results strongly suggest that CL is required
for the proper folding and/or interactions of the membrane subunits,
which, in turn, may be required to form an interactive surface with
the Fe–S protein and hence stabilize the complex. These results also in-
dicate that the loss of SQR activity that likely occurs with Complex II
dilapidation during mitochondrial solubilization is reversible upon re-
constitution with biomimetic lipids. Notably, a CL molecule was shown
to co-crystallize with the membrane subunits of the homologous com-
plex in E. coli [7]. CL was not observed in a homologous structure from
porcine [6]; however, the structure did contain two PE molecules,
which share non-bilayer propensity with CL.
To further conﬁrm that CL is required to maintain SQR activity, we
measured the speciﬁc activities of ND preparations made with differ-
ent lipids and isolated by our afﬁnity puriﬁcation procedure (normal-
ized with respect to the concentration of catalytic dimer FAD,
Table 1). Complex II reconstituted into NDs with CL had an approxi-
mately 9-fold higher speciﬁc activity than complexes reconstituted
with lipids containing similar acyl chain lengths (POPC and POPC/
POPE), and an approximately 85-fold higher activity than those in
the presence of short chain phospholipids (DMPC). Hence, even
when measured on a catalytic dimer-speciﬁc basis, CL enhances the
catalytic efﬁciency of Complex II. CL may therefore not only stabilize
the complex, as described above (Section 3.2), but also promote catal-
ysis by other mechanisms (see Conclusions section).
We further tested the effects of CL on Complex II activity in
organello. It has been reported that although CL is not absolutely re-
quired for OXPHOS activity, this lipid does enhance OXPHOS efﬁ-
ciency, particularly under unfavorable conditions [3,4,30]. For
example, S. cerevisiae Δcrd1mutants (lacking the gene encoding car-
diolipin synthase, CRD1), which have no CL in their mitochondrial
membranes, can grow in non-fermentable medium [31,32]. Yet
mitochondria from S. cerevisiae Δcrd1 strains show lower OXPHOS
activity at elevated temperatures [33] and have signiﬁcant uncoupling
(lower ADP/O ratio and higher state 4 respiration) at high respiration
rates [34]. To test for possible effects of CL on Complex II catalysis within
intact mitochondria, we compared SQR activity formitochondria isolat-
ed from wild type and Δcrd1 S. cerevisiae strains at 26 °C and at 40 °C.
At the lower temperature, wild type and Δcrd1 strains had similar
rates (0.098±0.0062 and 0.079±0.0069 μmol DCPIP reduced
min−1 mg mitochondrial protein−1, respectively). But at higher
temperature, whereas SQR activity from the wild type strain did
not change appreciably (~2% increase), that of the Δcrd1 strain was
reduced (~17% decrease). While these results support a role for CL
in the maintenance of Complex II stability and/or activity, they also
suggest that the absence of CL in intact mitochondria has less of
an effect on Complex II activity than it does in our reconstituted sys-
tem. This is likely due to a compensatory increase in the synthesis
1594 C.T. Schwall et al. / Biochimica et Biophysica Acta 1817 (2012) 1588–1596of other phospholipids (phosphatidylglycerol and PE) in Δcrd1
strains, which may partially replace the function of CL [31,35–37]
and see Section 3.4.
3.4. Phosphatidylglycerol partially assumes the role of CL in Complex II
activity
CL has several properties that may contribute to its role in energy
conserving membranes: its unique dimeric structure with four acyl
chains, its propensity to form non-bilayer structures in the presence
of divalent cations, and its anionic phosphodiester headgroup. Pho-
sphatidylglycerol (PG), like CL, is an anionic phospholipid. As an im-
mediate biosynthetic precursor to CL, PG does not accumulate to a
signiﬁcant extent in the mitochondrial IM. However, in S. cerevisiae
Δcrd1 null strains, the amount of PG increases to levels similar to
that of CL in wild type strains [31,35,37]. The notion that PG may par-
tially compensate for the lack of CL is underscored by inability of
strains lacking both PG and CL (with a null mutation in PGS1 which
encodes PG phosphate synthase) to grow on nonfermentable carbon
sources [31,38].
Our experimental system allowed us to directly test whether PG
could functionally replace the role of CL in Complex II structure and
function; more speciﬁcally, whether the anionic headgroup was re-
sponsible for maintaining holocomplex stability and/or redox activity.
Hence, we prepared samples with lipid mixtures of POPC, POPE,
and POPG in molar ratios of 40:40:20, respectively. When POPG-
containing NDs were subjected to our complex stability assay, a
large fraction of the Sdh1p was released early in the afﬁnity puriﬁca-
tion (Fig. 4A, lanes 3–7). We therefore conclude that, like the other
CL-lacking DMPC, POPC, and POPC/POPE preparations (Fig. 2), POPG-
containing NDs had a weak interaction between the membrane-boundFig. 4. Stability and enzymatic activity of Complex II reconstituted into NDs with POPG. (A
samples. Preparation of samples and column fraction designations are identical to those in F
in NDs containing either biomimetic lipids with CL (blue) or biomimetic-like lipids with POand catalytic subunits. On the other hand, POPG-containing NDs with
holocomplexes that remained after puriﬁcation displayed SQR activity
that approached that of CL-containing preparations, assayed by time
course measurements (Fig. 4B) and by FAD-normalized speciﬁc activity
(Table 1). Hence, while PG does not promote stability of Complex II,
it does appear to enhance catalysis. By extension, these results suggest
that the hydrophobic domain of CL is important for mediating complex
subunit interactions, whereas the anionic headgroup plays a role in pro-
moting redox activity.
3.5. The phospholipid-dependence of Complex II ROS production rates
The production of ROS (primarily O2−) by Complex II can result
from a block in the redox chain from succinate to Q [15]. Our observa-
tion that Complex II reconstituted with particular lipid combinations
in the absence of CL had negligible SQR activity (Fig. 3B, E* fraction)
but robust SDH activity (Fig. 3C, E* fraction) suggested that in these
cases, electrons from succinate oxidation may not be efﬁciently trans-
ferred to the Q-binding site and may therefore react with O2 to pro-
duce O2−. To test this, we measured the succinate-dependent
production of O2− by Complex II with all lipid combinations in the
presence of DB using the superoxide-speciﬁc reporter MitoSOX Red
(Fig. 5). In the presence of DMPC or POPC alone (Fig. 5, red and yellow
bars), Complex II had signiﬁcantly higher O2− production rates than
when reconstituted with biomimetic lipids (Fig. 5, blue bar), consis-
tent with the predicted block of electron ﬂux to the Q-binding site
in the former samples. As a control, Complex II in biomimetic NDs
that were pre-treated with TTFA had 44% higher O2− production
rates than mock-treated (ethanol only) samples, demonstrating that
our monitored ROS production was in fact from Complex II. Interest-
ingly, Complex II in the presence of POPG, having measured SQR) Elution proﬁles of NDs assembled with POPG replacing the CL present in biomimetic
ig. 2. (B) Signal-averaged time course traces of SQR activity for Complex II reconstituted
PG replacing the CL (orange).
Fig. 5. ROS formation as determined by MitoSOX ﬂuorescence analysis. Statistical signiﬁ-
cance identical to Fig. 3C, but statistics are represented in relation to biomimetic and
POPC/POPE NDs.
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king CL (Fig. 4B, Table 1), appeared to also have intermediate rates
of ROS production (Fig. 5, orange bar). Taken together, these results
are consistent with the prediction that a reduced efﬁciency of elec-
tron transfer from the catalytic dimer to the Q-site may result in ex-
cess electron leakage. Notably, however, this inverse relationship
between SQR catalytic efﬁciency and ROS production does not hold
for Complex II reconstituted with POPC/POPE. Whereas PE does not
markedly stabilize the holocomplex (Fig. 2) or promote SQR activity
(Fig. 3), it does appear to lower ROS production rates to levels compa-
rable to CL-containing samples (Fig. 5, green bar). We speculateFig. 6.Working model for the role of CL in the stability and catalytic activity of Complex II. In
activity. In the absence of CL (right panel), the soluble catalytic heterodimer is not as stably a
electrons to O2 to form O2−.that this may be related to the non-bilayer (HII) propensity of PE,
which could be a contributing factor in curtailing Complex II ROS
production.
4. Conclusions
We have presented evidence that CL is essential for the structure
and function of mitochondrial Complex II by: (i) maintaining the in-
teraction between the catalytic dimer and membrane subunits
(Fig. 2), (ii) promoting electron ﬂux from succinate to the Q reduction
site in the bilayer (Fig. 3), and (iii) reducing ROS production (Fig. 5).
Our results and working model are summarized in Fig. 6. We propose
that CL may stabilize the holocomplex by promoting the proper fold-
ing and/or helical packing interactions of the membrane subunits,
which may in turn present an interactive site for the Fe–S subunit
(Sdh2p/SdhB). Our observation that CL also enhances Complex II ca-
talysis per se (FAD-normalized SQR activity, Table 1) indicates that
it may assume a more direct catalytic function as it does for other re-
spiratory complexes. The catalytic Q site of Complex II is formed at
the interface of the Fe–S subunit and the two membrane subunits,
wherein amino acids from each subunit contribute to an extensive
hydrogen bonding network with the bound quinone [6–8,10,39].
The results from our analysis suggest that CL may be involved in sta-
bilizing these interactions, allowing conformational dynamics re-
quired for movement of the quinone into the catalytic site, and/or
facilitating the proton transfer pathway to the Q-site. CL forms a
resonance-stabilized bicyclic structure that is protonated at physio-
logical pH, and may therefore act as a proton sink that recruits
protons to speciﬁc sites within enzymes of energy-transducing mem-
branes [40,41]. In the yeast cytochrome bc1 complex, for example, a
single peripheral CL molecule is bound between monomers in prox-
imity to the quinone binding site, and this lipid has been implicated
in the conduction of protons from the bulk solvent to the quinone
[42,43]. A similar proton antenna function may also concentrate pro-
tons at the interfacial region near the quinone binding pocket ofthe presence of CL (left panel), the holocomplex is fully assembled and efﬁcient in SQR
ssociated with the membrane heterodimer, promoting the transfer of succinate-derived
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noteworthy that our POPG-containing preparations showed en-
hanced SQR activity (Fig. 4, Table 1), consistent with the notion that
this acidic phospholipid may also serve as an anionic proton antenna
as it might in the cytochrome b6f complex of thylakoid membranes
[44]. More recently, the activity of the respiratory complex NarGHI
in E. coli was shown to be enhanced by a CL molecule that binds in
the vicinity of the Q site, likely promoting the correct interaction
with the menaquinol substrate [45].
Our results add Complex II to the list of respiratory complexes that
require CL for optimal function and assembly. We note, however, that
during the largely uncharacterized assembly process of Complex II
in vivo (membrane subunit integration via the TIM23 Complex, lateral
interaction and heme coordination of SdhC/D [Sdh3p/4p], and assem-
bly with the catalytic dimer), the speciﬁc roles of CL may differ from
its functions in our reconstituted system. From a technical standpoint,
we have developed a novel approach for studying complexes taken
from a native biomembrane and reconstituted into a model bilayer
platform whose lipid composition can be precisely deﬁned. This ex-
perimental approach will be of particular use in analyzing possible
connections between lipid composition, membrane protein assembly,
and the molecular basis of diseases (e.g., CL deﬁciency associated with
Barth syndrome).
Supplementary data related to this article can be found online at
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